BioRestorative Therapies

BRTX • NASDAQ • Stock Fundamentals

BioRestorative Therapies is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lance Alstodt, with a market cap of $6.4M.

Market Cap$6.4M

Employees11.0

CEOLance Alstodt

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about BioRestorative Therapies

BioRestorative Therapies (BRTX) has a market capitalization of $6.4M and trades on NASDAQ.

BioRestorative Therapies has approximately 11 employees.